Skip to main content
Journal cover image

Adjuvant and mainstream treatments for depression, schizophrenia, obsessive-compulsive disorder, and cognitive impairment.

Publication ,  Journal Article
Koenig, HG
Published in: Int J Psychiatry Med
September 2024

Duke Scholars

Published In

Int J Psychiatry Med

DOI

EISSN

1541-3527

Publication Date

September 2024

Volume

59

Issue

5

Start / End Page

507 / 510

Location

United States

Related Subject Headings

  • Schizophrenia
  • Psychiatry
  • Obsessive-Compulsive Disorder
  • Humans
  • Depressive Disorder
  • Cognitive Dysfunction
  • 5203 Clinical and health psychology
  • 4206 Public health
  • 3202 Clinical sciences
  • 1701 Psychology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Koenig, H. G. (2024). Adjuvant and mainstream treatments for depression, schizophrenia, obsessive-compulsive disorder, and cognitive impairment. Int J Psychiatry Med, 59(5), 507–510. https://doi.org/10.1177/00912174241274420
Koenig, Harold G. “Adjuvant and mainstream treatments for depression, schizophrenia, obsessive-compulsive disorder, and cognitive impairment.Int J Psychiatry Med 59, no. 5 (September 2024): 507–10. https://doi.org/10.1177/00912174241274420.
Koenig, Harold G. “Adjuvant and mainstream treatments for depression, schizophrenia, obsessive-compulsive disorder, and cognitive impairment.Int J Psychiatry Med, vol. 59, no. 5, Sept. 2024, pp. 507–10. Pubmed, doi:10.1177/00912174241274420.
Journal cover image

Published In

Int J Psychiatry Med

DOI

EISSN

1541-3527

Publication Date

September 2024

Volume

59

Issue

5

Start / End Page

507 / 510

Location

United States

Related Subject Headings

  • Schizophrenia
  • Psychiatry
  • Obsessive-Compulsive Disorder
  • Humans
  • Depressive Disorder
  • Cognitive Dysfunction
  • 5203 Clinical and health psychology
  • 4206 Public health
  • 3202 Clinical sciences
  • 1701 Psychology